Genetic etiology of cardiac syndromes

Progress in Pediatric Cardiology

Volumn 6, Issue 1, 1996, Pages 29-41

  Pierpont, Mary Ella M ^a,b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Alagille syndrome; Cri du chat syndrome; Familial heterotaxy syndrome; Familial supravalvular aortic stenosis; Holt Oram syndrome; Noonan syndrome; Rubinstein Taybi syndrome; Total anomalous pulmonary venous return; Turner syndrome; Williams syndrome; Wolf Hirschhorn syndrome

Indexed keywords

ALAGILLE SYNDROME; AORTA SUPRAVALVULAR STENOSIS; CAT CRY SYNDROME; HOLT ORAM SYNDROME; LUNG VEIN DRAINAGE ANOMALY; MOLECULAR GENETICS; NOONAN SYNDROME; PRIORITY JOURNAL; REVIEW; RUBINSTEIN SYNDROME; TURNER SYNDROME; WILLIAMS BEUREN SYNDROME; WOLF HIRSCHHORN SYNDROME;

EID: 0030220278     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/1058-9813(96)00169-5     Document Type: Article

References (73)

1. [1] Wilson MG, Towner JW, Coffin GS, Ebbin AJ, Siris E, Brager P, Genetics and clinical studies in 13 patients with the Wolf-Hirschhorn syndrome [del(4p)]. Hum Genet 1981;59:297-307.
2. [2] Centerwall RW, Thompson WP, Allen IE, Fobes CD. Translocation 4p-syndrome. Am J Dis Child 1975;129:366-370.
3. [3] Gandelman KY, Gibson L, Meyn MS, Yang-Feng TL. Molecular definition of the smallest region of deletion overlap in the Wolf-Hirschhorn syndrome. Am J Hum Genet 1992;51:571-578.
4. [4] Estabrooks LL, Lamb AN, Aylsworth AS, Callanan NP, Rao KW. Molecular characterisation of chromosome 4p deletions resulting in Wolf-Hirschhorn syndrome. J Med Genet 1994;31:103-107.
5. [5] Goodship J, Curtis A, Cross I et al. A submicroscopic translocation, t(4;10), responsible for recurrent Wolf-Hirschhorn syndrome identified by allele loss and fluorescent in situ hybridisation. J Med Genet 1992;29:451-454.
6. [6] Tupler R, Bortotto L, Bühler EM et at. Paternal origin of the de novo deleted chromosome 4 in Wolf-Hirschhorn syndrome. J Med Genet 1992;29:53-55.
7. [7] Estabrooks LL, Rao KW, Driscoll DA et al. Preliminary phenotypic map of chromosome 4p16 based on 4p deletions. Am J Med Genet 1995;57:581-586.
8. [8] Bleyl S, Ruttenberg HD, Carey JC, Ward K. Familial total anomalous pulmonary venous return. Am J Med Genet 1994;52:462-466.
9. [9] Bleyl S, Nelson L, Odelberg SJ et al. A gene for familial total anomalous pulmonary venous return maps to chromosome 4p13-q12. Am J Hum Genet 1995;56:408-415.
10. [10] Niebuhr E. The Cri-du-chat syndrome. Hum Genet 1978;44:227-275.
11. [11] Overhauser J, Bengtsson U, McMahon J et al. Prenatal diagnosis and carrier detection of a cryptic translocation by using DNA markers from the short arm of chromosome 5. Am J Hum Genet 1989;45:296-303.
12. [12] Overhauser J, McMahon J, Oberlender S et al. Parental origin of chromosome 5 deletions in the cri-du-chat syndrome. Am J Med Genet 1990;37:83-86.
13. [13] Church DM, Bengtsson U, Nielsen KV, Wasmuth JJ, Niebuhr E. Molecular definition of deletions of different segments of distal 5p that result in distinct phenotypic features. Am J Hum Genet 1995;56:1162-1172.
14. [14] Overhauser J, Huang X, Gersh M et al. Molecular and phenotypic mapping of the short arm of chromosome 4: sublocalization of the critical region for the cri-du-chat syndrome. Hum Mol Genet 1994;3:247-252.
15. [15] Gersh M, Goodart SA, Pasztor LM, Harris DJ, Weiss L, Overhauser J. Evidence for a distinct region causing a cat-like cry in patients with 5p deletions. Am J Hum Genet 1995:56:1404-1410.
16. [16] Chiarella F, Bricarelli FD, Lupi G, Bellotti P, Domenicucci S, Vecchio C. Familial supravalvular aortic stenosis: a genetic study. J Med Genet 1989;26:86-92.
17. [17] Ensing GJ, Schmidt MA, Hagler DJ, Michels VV, Carter GA, Feldt RH. Spectrum of findings in a family with non-syndromic autosomal dominant supravalvular aortic stenosis: A doppler echocardiographic study. J Am Coll Cardiol 1989;13:413-419.
18. [18] Kumar A, Stalker HJ, Williams CA. Concurrence of supravalvular aortic stenosis and peripheral pulmonary stenosis in three generations of a family: A form of arterial dysplasia. Am J Med Genet 1993;45:739-742.
19. [19] Johnson LW, Fishman RA, Schneider B, Parker FB, Husson G, Webb WR. Familial supravalvular aortic stenosis. Chest 1976:70:494-500.
20. [20] Schmidt RE, Gilbert EF, Amend TC, Chamberlain CR, Lucas RV. Generalized arterial fibromuscular dysplasia and myocardial infarction in familial supravalvular aortic stenosis sydrome. J Pediatr 1969;74:576-584.
21. [21] Ewart AD, Morris CA, Ensing GJ et al. A human vascular disorder, supravalvular aortic stenosis maps to chromosome 7. Proc Natl Acad Sci USA 1993;90:3226-3230.
22. [22] Curran ME, Atkinson DL, Ewart AK, Morris CA, Leppert MF, Keating MT. The elastin gene is disrupted by a translocation associated with supravalvular aortic stenosis. Cell 1993;73:159-168.
23. [23] Ewart AK, Jin W, Atkinson D, Morris CA, Keating MT. Supravalvular aortic stenosis with a deletion disrupting the elastin gene. J Clin Invest 1994;93:1071-1077.
24. [24] Wessel A, Pankau R, Kececioglu D, Ruschewski W, Bürsch JH. Three, decades of follow-up of aortic and pulmonary vascular lesions in the Williams-Beuren syndrome. Am J Med Genet 1994;52:297-301.
25. [25] Zalzstein E, Moes CAF, Musewe NN, Freedom RM. Spectrum of cardiovasuclar anomalies in Williams-Beuren syndrome. Pediatr Cardiol 1991;12:219-223.
26. [26] Giddins NG, Finley JP, Nanton MA, Roy DL. The natural course of suprvalvar aortic stenosis and peripheral pulmonary artery stenosis in Williams's syndrome. Br Heart J 1989;62:315-319.
27. [27] Ardinger RH, Goertz KK, Mattioli LF. Cerebrovascular stenoses with cerebral infarction in a child with Williams syndrome. Am J Med Genet 1994;51:200-202.
28. [28] Morris CA, Thomas IT, Greenberg F. Williams sydnrome: Autosomal dominant inheritance. Am J Med Genet 1993;47:478-481.
29. [29] Ewart AK, Morris CA, Atkinson D et al. Hemizygosity at the elastin locus in a developmental disorder, Williams syndrome. Nature Genet 1993;5:11-16.
30. [30] Lowery MC, Morris CA, Ewart A et al. Strong correlation of elastin deletions, detected by FISH, with Williams syndrome: Evaluation of 235 patients. Am J Hum Genet 1995;57:49-53.
31. [31] Smith AT, Sack GH, Taylor GJ. Holt-Oram syndrome. J Pediatr 1979;95:538-543.
32. [32] Basson CT, Cowley GS, Solomon SC et al. The clinical and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome). N Engl J Med 1994;330:885-891.
33. [33] Sletton LJ, Pierpont ME. Variation in severity of cardiac disease in Holt-Oram syndrome. Am J Med Genet 1996 (in press).
34. [34] Bonnet D, Pelet A, Legeai-Mallet L et al. A gene for Holt-Oram syndrome maps to the distal long arm of chromosome 12. Nature Genet 1994;6:405-408.
35. [35] Terrett JA, Newbury-Ecob R, Cross GS et al. Holt-Oram syndrome is a genetically heterogeneous disease with one locus mapping to human chromosone 12q. Nature Genet 1994;6:401-404.
36. [36] Bonnet D, Terrett J, Pequignot-Viegas E et al. Localisation d'un gène du syndrome atrio-digital de Holt-Oram en 12q2. Arch Mal Coeur 88:661-666.
37. [37] Basson CT, Solomon SC, Weissman B et al. Genetic heterogeneity of heart-hand syndromes. Circulation 1995;91:1326-1329.
38. [38] Allanson JE, Hall JG, Hughes HE, Preus M, Witt RD. Noonan syndrome: The changing phenotype. Am J Med Genet 1985;21:507-514.
39. [39] Mendez HMM, Opitz JM. Noonan syndrome: A review. Am J Med Genet 1985;21:493-506.
40. [40] Burch M, Sharland M, Shinebourne E, Smith G, Patton M, McKenna W. Cardiologic abnormalities in Noonan syndrome: Phenotypic diagnosis and echocardiographic assessment of 118 patients. J Am Coll Cardiol 1993;22:1189-1192.
41. [41] Burch M, Mann JM, Sharland M, Shinebourne EA, Patton MA, McKenna WJ. Myocardial disarray in Noonan syndrome. Br Heart J 1992;68:586-588.
42. [42] Jamieson CR, van der Burgt I, Brady AF et al. Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nature Genet 1994;8:357-360.
43. [43] Tommerup N, van der Hagen CB, Heiberg A. Tentative assignment of a locus for Rubinstein-Taybi syndrome to 16p13.3 by a de novo reciprocal translocation, t(7;16) (q34;p13.3). Am J Med Genet 1992;44:237-241.
44. [44] Rubinstein JH, Broad thumb-hallux (Rubinstein-Taybi) syndrome 1957-1988. Am J Med Genet 1990;suppl 6:3-16.
45. [45] Allanson JE. Rubinstein-Taybi syndrome: The changing face. Am J Med Genet Suppl 1990,6:38-41.
46. [46] Stevens CA, Bhakta MG. Cardiac abnormalities in the Rubinstein-Taybi syndrome. Am J Med Genet 1995;59:346-348.
47. [47] Hennekam RCM, Lommen EJP, Strengers JLM, VanSpijker HG, Jansen-Kokx TMG. Rubinstein-Taybi syndrome in a mother and son. Eur J Pediatr 1989;148:439-441.
48. [48] Breuning MH, Dauwerse HG, Fugazza G et al. RubinsteinTaybi syndrome caused by submicroscopic deletions within 16p13.3. Am J Hum Genet 1993;52:249-254.
49. [49] Hennekam RCM, Tilanus M, Hamel BCJ et al. Deletion at chromosome 16p13.3 as a cause of Rubinstein-Taybi syndrome: Clinical aspects. Am J Hum Genet 1993;52:255-262.
50. [50] Petrij F, Giles RH, Dauwerse JG et al. Single gene for Rubinstein-Taybi syndrome on chromosome 16 identified: the transcriptional co-activator CBP. Am J Hum Genet 1995;57:A3.
51. [51] Alagille D, Odièvre, Gautier M, Dommergues JP. Hepatic ductular hypoplasia associated with characteristic facies, vertebral malformations, retarded physical, mental and sexual development, and cardiac murmur. J Pediatr 1975;86:63-71.
52. [52] Cardona J, Houssin D, Gauthier F et al. Liver transplantation in children with Alagille syndrome-a study of twelve cases. Transplantation 1995;60:339-342.
53. [53] Silberbach M, Lashley D, Reller MD, Kinn WF, Terry A, Sunderland CO. Arteriohepatic dysplasia and cardiovascular malformations, Am Heart J 1994;127:695-699.
54. [54] Pombo F, Isla C, Gayol A, Bargiela A. Aortic calcification and renal cysts demonstrated by CT in a teenager with Alagille syndrome. Pediatr Radiol 1995;25:314-315.
55. [55] Shulman SA, Hyams JS, Gunta R, Greenstein RM, Cassidy SB. Arteriohepatic dysplasia (Alagille syndrome): Extreme variability among affected family members. Am J Med Genet 1984;19:325-332.
56. [56] Byrne JLB, Harrod MJE, Friedman JM, Howard-Peebles PN. Del(20p) with manifestations of arteriohepatic dysplasia. Am J Med Genet 1986;24:673-678.
57. [57] Schnittger S, Höfers, Heidemann P, Beermann F, Hansmann I. Molecular and cytogenetic analysis of an interstitial 20p deletion associated with syndromic intrahepatic ductular hypoplasia (Alagille syndrome). Hum Genet 1989;83:239-244.
58. [58] Deleuze JF, Hazan J, Dhorne S, Weissenbach J, Hadchouel M. Mapping of microsatellite markers in the Alagille region and screening of microdeletions by genotyping 23 patients. Eur J Hum Genet 1994;2:185-190.
59. [59] Spinner NB, Rand EB, Fortina P et al. Cytologically balanced t(2;20) in a two-generation family with Alagille syndrome: Cytogenetic and molecular studies. Am J Hum Genet 1994;55:238-243.
60. [60] Rand EB, Spinner NB, Piccoli DA, Whitington PF, Taub RB. Molecular analysis of 24 Alagille syndrome families identifies a single submicroscopic deletion and further localizes the Alagille region within 20p12. Am J Hum Genet 1995;57:1068-1073.
61. [61] Pollet N, Dhorne-Pollet S, Deleuze JF et al. Construction of a 3.7-Mb physical map within human chromosome 20p12 ordering 18 markers in the Alagille syndrome locus. Genomics 1995;27:467-474.
62. [62] Gotzsche CO, Krag-Olsen B, Nielsen J, Sorensen KE, Kristensen BO. Prevalence of cardiovascular malformations and association with karyotypes in Turner's syndrome. Arch Dis Child 1994;71:433-436.
63. [63] Lin AE, Lippe BM, Geffner ME et al. Aortic dilation, dissection, and rupture in patients with Turner syndrome. J Pediatr 1986;109:820-826.
64. [64] Van Egmond H, Orye E, Praet M, Coppens M, DevlooBlancquaert A. Hypoplastic left heart syndrome and 45X karyotype. Br Heart J 1988;60:69-71.
65. [65] Berdahl LD, Wenstrom KD, Hanson JW. Web neck anomaly and its association with congenital heart disease. Am J Med Genet 1995;56:304-307.
66. [66] Allen DB, Hendricks A, Levy JM. Aortic dilation in Turner syndrome. J Pediatr 1986;109:302-305.
67. [67] Palmer CG, Reichmann A. Chromosomal and clinical findings in 110 females with Turner syndrome. Hum Genet 1976;35:35-49.
68. [68] Lorda-Sanchez I, Binkert F, Maechler M, Schinzel A. Molecular study of 45,X conceptuses: Correlation with clinical findings. Am J Med Genet 1992;42:487-490.
69. [69] Coto E, Toral JF, Menendez MJ et al. PCR-based study of the presence of Y-chromosome sequences in patients with Ullrich-Turner syndrome. Am J Med Genet 1995;57:393-396.
70. [70] Grompe M, Rao N, Elder FFB, Caskey CT, Greenberg F. 45,X/46,X, +r(X) can have a distinct phenotype different from Ullrich-Turner syndrome. Am J Med Genet 1992;42:39-43.
71. [71] Migeon BR, Luo S, Jani M, Jeppesen P. The severe phenotype of females with tiny ring X chromosomes is associated with inability of these chromosomes to undergo X inactivation. Am J Hum Genet 1994:55:497-504.
72. [72] Jani MM, Torchia BS, Pai GS, Migeon BR. Molecular characterization of tiny ring X chromosomes from females with functional X chromosome disomy and lack of cis X inactivation. Genomics 1995;27:182-188.
73. [73] Casey B, Devoto M, Jones KL, Ballabio A. Mapping a gene for familial situs abnormalities to human chromosome Xq24-q27.1. Nature Genet 1993;5:403-407.